New Long-Lasting pain shot could reduce need for opioids after surgery
NCT ID NCT07271979
Summary
This study is testing whether a new, long-lasting numbing medicine (liposomal bupivacaine) works better than a standard one (ropivacaine) at reducing pain after major abdominal surgery. Doctors will inject one of these medicines into the surgical area right before closing the incision in 146 patients. The main goal is to see which medicine provides better pain control in the first day after surgery and reduces the need for strong painkillers like opioids.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANALGESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, China
Conditions
Explore the condition pages connected to this study.